Loading company…
Mynvax, based in Bangalore, is a clinical-stage vaccine company developing thermostable protein subunit vaccines.
Founded in 2017 and based in Karnataka, India, Mynvax Private Limited was founded by Gautham Nadig and Raghavan Varadarajan. It develops thermostable vaccines, mainly protein subunit vaccines, against respiratory viral infections and COVID-19, and its lead product is a thermotolerant COVID-19 vaccine formulation. In May 2024 the company raised USD 2.6 million in seed funding led by Inviga and Legacy Assets LLP.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in